# Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.

> **NCT01193335** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 200 (actual)

## Conditions studied

- 13-valent Pneumococcal Vaccine
- Premature Birth
- Immunization
- Safety

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine
- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT01193335
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01193335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01193335, "Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01193335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*